Two Biotechs I’m Buying Amid an Overbought Market
As retailers get hit and AI-plays bubble over, I’ve got my sights on these two promising biopharma stocks.
As retailers get hit and AI-plays bubble over, I’ve got my sights on these two promising biopharma stocks.
I’m looking forward to a break from the heat, but not to these economic worries that could add to already poor seasonality.
Plus, connecting the July data for Housing Starts and Industrial Production to two Portfolio holdings.
The home improvement retailers appears to be headed in the right direction.
Nvidia backs OpenAI in Ohio, Costco pilots Medicare plans and other headlines moving the market this morning.
As peace eludes and perils grow in Middle East, why hasn’t oil run wild … yet? Also, the ‘BUZZ’ on chips and trouble n China.
The bearish argument is logical, but price action refuses to confirm it. Here’s what could change things.
We added to one holding this week, and locked in outsized gains for two others.
Weak retail sales gapped the market up but it rolled over anyway.
Here’s my game plan and take on the market action, incoming economic data, and volatile geopolitical scene.